The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Myotonic Dystrophy
Open accessAbstract
Myotonic dystrophy (dystrophia myotonica, DM) is one of the most common lethal monogenic disorders in populations of European descent. Myotonic dystrophy type 1 (DM1) was first described over a century ago. DM1 is caused by expansion of a CTG triplet repeat in the 3' non-coding region of DMPK, the gene encoding the DM protein kinase. More recently a second form of the disease, myotonic dystrophy type 2 (DM2) was recognized, which results from repeat expansion in a different gene. The DM2 expansion involves a CCTG repeat in the first intron of Zinc Finger 9 (ZNF9). Both disorders have autosomal dominant inheritance and multisystem features, including myotonic myopathy, cataract, and cardiac conduction disease. Studies suggest that the shared clinical features of DM1 and DM2 involve a novel genetic mechanism in which repetitive RNA exerts a toxic effect. The RNA toxicity stems from the expanded repeat in the transcripts from the mutant DM alleles. This chapter will review the clinical presentation and pathophysiology of DM, and discuss current management and future potential for developing targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,231
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Repeat instability: mechanisms of dynamic mutations
Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 903
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L. T., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citationFoci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.
Taneja, K. L., McCurrach, M., Schalling, M., Housman, D., & Singer, R. H. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.995 · Cited by 599
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541
Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., & Thornton, C. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh327 · Cited by 526
Self-citationElectrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa062800 · Cited by 511
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl132 · Cited by 510
Self-citationTargeting nuclear RNA for in vivo correction of myotonic dystrophy
Wheeler, T. M., Leger, A. J., Pandey, S. K., MacLeod, A. R., Nakamori, M., Cheng, S. H., Wentworth, B. M., Bennett, C. F., & Thornton, C. A. (2012) · Nature · doi:10.1038/nature11362 · Cited by 502
Self-citationMuscleblind proteins regulate alternative splicing
Ho, T. H., Charlet‐B, N., Poulos, M. G., Singh, G., Swanson, M. S., & Cooper, T. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600300 · Cited by 494
Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins
Wang, E. T., Cody, N. A. L., Jog, S., Biancolella, M., Wang, T. T., Treacy, D. J., Luo, S., Schroth, G. P., Housman, D. E., Reddy, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.041 · Cited by 490
Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H., & Housman, D. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7388 · Cited by 470
Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum
Day, J. W., Ricker, K., Jacobsen, J. F., Rasmussen, L. J., Dick, K. A., Kress, W., Schneider, C., Koch, M. C., Beilman, G. J., Harrison, A. R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000054481.84978.f9 · Cited by 467
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
Mankodi, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2165 · Cited by 458
Kuyumcu-Martinez, N. M., Wang, G.-S., & Cooper, T. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.027 · Cited by 445
Kanadia, R. N., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604970103 · Cited by 371
Self-citationTsilfidis, C., MacKenzie, A. E., Mettler, G., Barceló, J., & Korneluk, R. G. (1992) · Nature Genetics · doi:10.1038/ng0692-192 · Cited by 350
Fugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2374 · Cited by 335
Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes
Thornton, C. A., Johnson, K., & Moxley, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410350116 · Cited by 275
Self-citationAge and causes of death in adult-onset myotonic dystrophy
de Die-Smulders, C. (1998) · Brain · doi:10.1093/brain/121.8.1557 · Cited by 266
Splicing biomarkers of disease severity in myotonic dystrophy
Nakamori, M., Sobczak, K., Puwanant, A., Welle, S., Eichinger, K., Pandya, S., Dekdebrun, J., Heatwole, C. R., McDermott, M. P., Chen, T., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23992 · Cited by 265
Self-citationTriplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905780106 · Cited by 257
Self-citationTIAN, B., WHITE, R. J., XIA, T., WELLE, S., TURNER, D. H., MATHEWS, M. B., & THORNTON, C. A. (2000) · RNA · doi:10.1017/s1355838200991544 · Cited by 249
Self-citationCerebral involvement in myotonic dystrophies
Meola, G., & Sansone, V. (2007) · Muscle & Nerve · doi:10.1002/mus.20800 · Cited by 232
RNA‐mediated neurodegeneration in repeat expansion disorders
Todd, P. K., & Paulson, H. L. (2010) · Annals of Neurology · doi:10.1002/ana.21948 · Cited by 226
A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding
Arambula, J. F., Ramisetty, S. R., Baranger, A. M., & Zimmerman, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901824106 · Cited by 221
The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease
Minnerop, M., Weber, B., Schoene-Bake, J.-C., Roeske, S., Mirbach, S., Anspach, C., Schneider-Gold, C., Betz, R. C., Helmstaedter, C., Tittgemeyer, M., et al. (2011) · Brain · doi:10.1093/brain/awr299 · Cited by 216
Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)
Heatwole, C., Bode, R., Johnson, N., Quinn, C., Martens, W., McDermott, M. P., Rothrock, N., Thornton, C., Vickrey, B., Victorson, D., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318260cbe6 · Cited by 214
Self-citationOsborne, R. J., & Thornton, C. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl181 · Cited by 213
Self-citationRedman, J. B. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150072029 · Cited by 210
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
Logigian, E. L., Martens, W. B., Moxley, R. T., McDermott, M. P., Dilek, N., Wiegner, A. W., Pearson, A. T., Barbieri, C. A., Annis, C. L., Thornton, C. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a3a · Cited by 203
Self-citationCompound loss of muscleblind‐like function in myotonic dystrophy
Lee, K., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S. A., Chamberlain, C. M., Finn, D., Hong, H., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303275 · Cited by 190
Somatic instability of CTG repeat in myotonic dystrophy
Ashizawa, T., Dubel, J. R., & Harati, Y. (1993) · Neurology · doi:10.1212/wnl.43.12.2674 · Cited by 188
Tang, Z. Z., Yarotskyy, V., Wei, L., Sobczak, K., Nakamori, M., Eichinger, K., Moxley, R. T., Dirksen, R. T., & Thornton, C. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr568 · Cited by 181
Self-citationRibonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2
Mankodi, A., Teng‐Umnuay, P., Krym, M., Henderson, D., Swanson, M., & Thornton, C. A. (2003) · Annals of Neurology · doi:10.1002/ana.10763 · Cited by 179
Self-citationBraida, C., Stefanatos, R. K. A., Adam, B., Mahajan, N., Smeets, H. J. M., Niel, F., Goizet, C., Arveiler, B., Koenig, M., Lagier‐Tourenne, C., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq015 · Cited by 165
Artero, R., Prokop, A., Paricio, N., Begemann, G., Pueyo, I., Mlodzik, M., Perez-Alonso, M., & Baylies, M. K. (1998) · Developmental Biology · doi:10.1006/dbio.1997.8833 · Cited by 160
Cold extends electromyography distinction between ion channel mutations causing myotonia
Fournier, E., Viala, K., Gervais, H., Sternberg, D., Arzel-Hézode, M., Laforêt, P., Eymard, B., Tabti, N., Willer, J. C., Vial, C., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20905 · Cited by 153
Bachinski, L. L., Udd, B., Meola, G., Sansone, V., Bassez, G., Eymard, B., Thornton, C. A., Moxley, R. T., Harper, P. S., Rogers, M. T., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378566 · Cited by 142
Self-citationTrip, J., Drost, G., van Engelen, B. G. M., & Faber, C. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004762.pub2 · Cited by 140
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy.
Ashizawa, T., Anvret, M., Baiget, M., Barceló, J. M., Brunner, H. G., Cobo, A. M., Dallapiccola, B., Fenwick, R. G., Grandell, U., & Harley, H. G. (1994) · PubMed Central · Cited by 137
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy
MacDonald, J. R., Hill, J. D., & Tarnopolsky, M. A. (2002) · Neurology · doi:10.1212/01.wnl.0000037481.08283.51 · Cited by 131
PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1
Wang, G., Kuyumcu‐Martinez, M. N., Sarma, S., Mathur, N., Wehrens, X. H. T., & Cooper, T. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37976 · Cited by 129
Cancer Risk Among Patients With Myotonic Muscular Dystrophy
Gadalla, S. M., Lund, M., Pfeiffer, R. M., Gørtz, S., Mueller, C. M., Moxley, R. T., Kristinsson, S. Y., Björkholm, M., Shebl, F. M., Hilbert, J. E., et al. (2011) · JAMA · doi:10.1001/jama.2011.1796 · Cited by 122
Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy
Lueck, J. D., Mankodi, A. K., Swanson, M. S., Thornton, C. A., & Dirksen, R. T. (2006) · The Journal of General Physiology · doi:10.1085/jgp.200609635 · Cited by 114
Self-citationMargolis, J., Schoser, B. G. H., Moseley, M. L., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl103 · Cited by 112
Randomized controlled trial of testosterone in myotonic dystrophy
Griggs, R. C., Pandya, S., Florence, J. M., Brooke, M. H., Kingston, W. J., Miller, J. P. V., Chutkow, J. G., Herr, B. E., & Moxley, R. T. (1989) · Neurology · doi:10.1212/wnl.39.2.219 · Cited by 111
Nuclear RNA Foci in the Heart in Myotonic Dystrophy
Mankodi, A. K., Lin, X., Blaxall, B. C., Swanson, M. S., & Thornton, C. A. (2005) · Circulation Research · doi:10.1161/01.res.0000193598.89753.e3 · Cited by 108
Self-citationUdd, B., Meola, G., Krahe, R., Thornton, C. A., Ranum, L. P. W., Bassez, G., Kress, W., Schoser, B. G. H., & Moxley, R. T. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.03.010 · Cited by 107
Self-citationDaytime sleep in myotonic dystrophy is not caused by sleep apnoea.
van der Meché, F. G. A., BOGAARD, J. M., van der Sluys, J., Schimsheimer, R. J., Ververs, C. C. M., & Busch, H. F. M. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.5.626 · Cited by 102
A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1
Laberge, L., Bégin, P., Dauvilliers, Y. A., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.165035 · Cited by 101
Increased Cancer Risks in Myotonic Dystrophy
Win, A. K., Perattur, P. G., Pulido, J. S., Pulido, C. M., & Lindor, N. M. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.09.005 · Cited by 100
Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1
Douniol, M., Jacquette, A., Cohen, D., Bodeau, N., Rachidi, L., Angeard, N., Cuisset, J., Vallée, L., Eymard, B., Plaza, M., et al. (2012) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2012.04379.x · Cited by 98
Ekström, A., Hakenäs‐Plate, L., Tulinius, M., & Wentz, E. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03300.x · Cited by 96
Daytime Sleepiness and REM Sleep Characteristics in Myotonic Dystrophy: A Case-Control Study
Yu, H., Laberge, L., Jaussent, I., Bayard, S., Scholtz, S., Morales, R. J., Pages, M., & Dauvilliers, Y. A. (2011) · SLEEP · doi:10.1093/sleep/34.2.165 · Cited by 95
Logigian, E. L., Ciafaloni, E., Quinn, L. C., et al. (2007) · Muscle & Nerve · doi:10.1002/mus.20722 · Cited by 93
Ethnic distribution of myotonic dystrophy gene
Ashizawa, T., & Epstein, H. F. (1991) · The Lancet · doi:10.1016/0140-6736(91)90659-d · Cited by 91
Reduction of the Rate of Protein Translation in Patients with Myotonic Dystrophy 2
Huichalaf, C. H., Schoser, B. G. H., Schneider‐Gold, C., Jin, B., Sarkar, P. S., & Timchenko, L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1983-09.2009 · Cited by 90
Bhakta, D., Groh, M. R., Shen, C., Pascuzzi, R. M., & Groh, W. J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.032 · Cited by 89
Frequency and stability of the myotonic dystrophy type 1 premutation
Martorell, L., Monckton, D. G., Sánchez, A., de Munaín, A. L., & Baiget, M. (2001) · Neurology · doi:10.1212/wnl.56.3.328 · Cited by 88
Reducing Levels of Toxic RNA with Small Molecules
Coonrod, L. A., Nakamori, M., Wang, W., Carrell, S., Hilton, C. L., Bodner, M. J., Siboni, R. B., Docter, A. G., Haley, M. M., Thornton, C. A., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400431f · Cited by 87
Self-citationZatz, M., Passos-Bueno, M., Cerqueira, A., Marie, S. K., Vainzof, M., & Pavanello, R. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.3.401 · Cited by 86
Intergenerational stability of the myotonic dystrophy protomutation
Barceló, J. M., Mahadevan, M. S., Tsilfidis, C., MacKenzie, A., & Korneluk, R. G. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.705 · Cited by 84
The hypocretin neurotransmission system in myotonic dystrophy type 1
Ciafaloni, E., Mignot, E. J.-M., Sansone, V., Hilbert, J. E., Lin, L. L., Lin, X., Liu, L. C., Pigeon, W. R., Perlis, M. L., & Thornton, C. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296827.20167.98 · Cited by 84
Self-citationViral vector producing antisense RNA restores myotonic dystrophy myoblast functions
Furling, D., Doucet, G., Langlois, M., Timchenko, L., Belanger, E., Cossette, L. J., & Puymirat, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301955 · Cited by 81
Temmerman, N. D., Sermon, K., Seneca, S., Rycke, M. D., Hilven, P., Lissens, W., Steirteghem, A. V., & Liebaers, I. (2004) · The American Journal of Human Genetics · doi:10.1086/422762 · Cited by 79
Ofori, L. O., Hoskins, J. W., Nakamori, M., Thornton, C. A., & Miller, B. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks298 · Cited by 77
Self-citationDecreased insulin sensitivity of forearm muscle in myotonic dystrophy.
Moxley, R. T., Griggs, R. C., Goldblatt, D., Vangelder, V., Herr, B. E., & Thiel, R. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109198 · Cited by 73
Absence of a differentiation defect in muscle satellite cells from DM2 patients
Pelletier, R., Hamel, F., Beaulieu, D., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.009 · Cited by 72
A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1)
Angeard, N., Jacquette, A., Gargiulo, M., Radvanyi, H., Moutier, S., Eymard, B., & Héron, D. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.04.009 · Cited by 72
Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec
Yotova, V., Labuda, D., Ziętkiewicz, E., Gehl, D., Lovell, A. D., Lefebvre, J.-F., Bourgeois, S., Lemieux‐Blanchard, É., Labuda, M., Vézina, H., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-1298-8 · Cited by 69
Vlachopapadopoulou, E., Zachwieja, J., Gertner, J., Manzione, D., Bier, D. M., Matthews, D. E., & Slonim, A. (1995) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.80.12.8530624 · Cited by 68
Premutation allele pool in myotonic dystrophy type 2
Bachinski, L. L., Czernuszewicz, T. J., Ramagli, L. S., Suominen, T., Shriver, M. D., Udd, B., Siciliano, M. J., & Krahe, R. (2008) · Neurology · doi:10.1212/01.wnl.0000333665.01888.33 · Cited by 68
Mechanisms and management of the heart in myotonic dystrophy
McNally, E. M., & Sparano, D. M. (2011) · Heart · doi:10.1136/hrt.2010.214197 · Cited by 68
Orlikowski, D., Chevret, S., Quera‐Salvá, M. A., Laforêt, P., Lofaso, F., Verschueren, A., Pouget, J., Eymard, B., & Annane, D. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.08.007 · Cited by 56
Heatwole, C. R., Eichinger, K. J., Friedman, D. I., Hilbert, J. E., Jackson, C. E., Logigian, E. L., Martens, W. B., McDermott, M., Pandya, S. K., Quinn, C. M., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.227 · Cited by 56
Self-citationMartorell, L., Cobo, A. M., Baiget, M., Naudó, M., Poza, J. J., & Parra, J. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1627 · Cited by 49
Wozniak, J. R., Mueller, B. A., Bell, C. J., Muetzel, R. L., Lim, K. O., & Day, J. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6771-4 · Cited by 48
Consensus on cerebral involvement in myotonic dystrophy
Bugiardini, E., & Meola, G. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.01.013 · Cited by 46
Epidemiological and Genetic Studies of Myotonic Dystrophy Type 1 in Taiwan
Hsiao, K., Chen, S.-H., Li, S.-Y., Chiang, S.-M., Lin, H.-M., Pan, H., Huang, C., Kuo, H., Jou, S., Su, C. C., et al. (2003) · Neuroepidemiology · doi:10.1159/000071191 · Cited by 37
Bachinski, L. L., Baggerly, K., Neubauer, V. L., Nixon, T. J., Raheem, O., Sirito, M., Unruh, A. K., Zhang, J., Nagarajan, L., Timchenko, L., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.11.001 · Cited by 36
Gadalla, S. M., Pfeiffer, R. M., Kristinsson, S. Y., Björkholm, M., Hilbert, J. E., Moxley, R. T., Landgren, O., & Greene, M. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079851 · Cited by 29
Cardani, R., Mancinelli, E., Saino, G., Bonavina, L., & Meola, G. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.06.366 · Cited by 22
Cited by
A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management
Lagrue, E., Dogan, C., De Antonio, M., Audic, F., Bach, N., Barnerias, C., Bellance, R., Cances, C., Chabrol, B., Cuisset, J.-M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006948 · Cited by 76
RNA-Targeted Therapies and High-Throughput Screening Methods
Zhu, S., Rooney, S., & Michlewski, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082996 · Cited by 41
Metadata
- Authors
- Thornton, C. A.
- Venue
- Neurologic Clinics
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 32
- Issue
- 3
- Pages
- 705-719
- ISSN
- 0733-8619 (ISSN-L)
- OpenAlex
- W4211120586
- Cited by
- 377
- References
- 89
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.